These results underscore the oncogenic role of PTBP3 and suggest that targeting PTBP3‐mediated COX11 splicing regulation may provide a promising therapeutic approach to inhibit peritoneal metastasis in gastric cancer (Figure8). This evidence concerns the gene PTBP3 and gastric cancer.